Skip to main content
. 2021 Nov 12;21:537. doi: 10.1186/s12872-021-02356-0

Table 3.

Clinical outcomes up to 3 years follow-up

Endpoint 0–1 year
n (%)
1–2 year
n (%)
2–3 year
n (%)
0–3 years
n (%)
Target lesion failure 76 (3.1%) 57 (2.3%) 35 (1.4%) 168 (6.8%)
 Cardiac death 44 (1.8%) 24 (1.0%) 26 (1.0%) 94 (3.8%)
 Target non-fatal vessel MI 9 (0.4%) 6 (0.2%) 3 (0.1%) 18 (0.7%)
 Clinically driven TLR 34 (1.3%) 30 (1.2%) 9 (0.4%) 73 (2.9%)
Definite stent thrombosis 5 (0.2%) 0 (0%) 1 (0.04%) 6 (0.2%)
Definite/Probable stent thrombosis 10 (0.4%) 2 (0.1%) 1 (0.04%) 13 (0.5%)